Future investigations should aim to dissect the tissue-specific functions of SIRT3, explore its molecular crosstalk with other apoptotic regulators, and evaluate its potential as a therapeutic target in aging-related disorders such as cancer. This evidence concerns the gene SIRT3 and cancer.